Dixestivo

2024

1. A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study)

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 821-833

2. Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11)

   Gastroenterologia y Hepatologia

3. Adherence to patient blood management strategy in patients with gastrointestinal bleeding: a prospective nationwide multicenter study

   European Journal of Gastroenterology and Hepatology

4. Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 337-346

5. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial

   The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 802-810

6. Applicability of the Barcelona scale to assess the quality of cleanliness of mucosa at esophagogastroduodenoscopy

   Gastroenterologia y Hepatologia, Vol. 47, Núm. 3, pp. 246-252

7. Artificial intelligence-assisted identification and retrieval of chronic hepatitis C patients lost to follow-up in the health area of Pontevedra and O Salnés (Spain)

   Gastroenterologia y Hepatologia

8. Baiona's Consensus Statement for Fecal Incontinence. Spanish Association of Coloproctology

   Cirugia Espanola, Vol. 102, Núm. 3, pp. 158-173

9. CTNND1 is involved in germline predisposition to early-onset gastric cancer by affecting cell-to-cell interactions

   Gastric Cancer, Vol. 27, Núm. 4, pp. 747-759

10. Characterizing Hepatitis Delta in Spain and the gaps in its management

    Gastroenterologia y Hepatologia

11. Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

    Therapeutic Advances in Gastroenterology, Vol. 17

12. Clinical settings with tofacitinib in ulcerative colitis

    Revista Espanola de Enfermedades Digestivas, Vol. 116, Núm. 9, pp. 484-492

13. Colonoscopy Satisfaction and Safety Questionnaire based on patient experience (CSSQP): A valuable quality tool for all colonoscopies

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 1, pp. 1-13

14. Colorectal cancer recurrence and its impact on survival after curative surgery: An analysis based on multistate models

    Digestive and Liver Disease, Vol. 56, Núm. 7, pp. 1229-1236

15. Combination of granulocyte–monocyte apheresis and tofacitinib: Multicentre and retrospective study

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 7, pp. 727-733

16. Combination of granulocyte–monocyte apheresis and ustekinumab: Multicentre and retrospective study

    Gastroenterologia y Hepatologia

17. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

18. Contraceptive Recommendations for Women with Immune-Mediated Inflammatory Diseases: A Delphi Consensus

    Advances in Therapy, Vol. 41, Núm. 4, pp. 1372-1384

19. Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry

    European Journal of Pediatrics, Vol. 183, Núm. 8, pp. 3567-3578

20. Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 10, pp. 2062-2074.e11